跳至主要内容
临床试验/NL-OMON21366
NL-OMON21366尚未招募不适用

Safety and Tolerability of Nebulized Amoxicillin-Clavulanic Acid in Acute Exacerbations of COPD.

Medisch Spectrum Twente0 个研究点目标入组 8 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
8

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. A clinical diagnosis of COPD, as defined by GOLD criteria;
  • 2. Hospitalized for an acute exacerbation of COPD;

排除标准

  • 1. Current pneumonia, defined as an acute respiratory tract illness associated with radiographic shadowing on a X-ray or CT-scan of the chest which was neither pre-existing nor of any other cause;
  • 2. Allergy for penicillin, amoxicillin or clavulanic acid. (patients must have been treated with amoxicillin before without a report of allergic reactions);

研究者

相似试验